vs
Side-by-side financial comparison of APTARGROUP, INC. (ATR) and WOLVERINE WORLD WIDE INC (WWW). Click either name above to swap in a different company.
APTARGROUP, INC. is the larger business by last-quarter revenue ($962.7M vs $517.5M, roughly 1.9× WOLVERINE WORLD WIDE INC). APTARGROUP, INC. runs the higher net margin — 7.7% vs 6.1%, a 1.6% gap on every dollar of revenue. On growth, WOLVERINE WORLD WIDE INC posted the faster year-over-year revenue change (25.5% vs 13.5%). WOLVERINE WORLD WIDE INC produced more free cash flow last quarter ($145.6M vs $96.9M). Over the past eight quarters, WOLVERINE WORLD WIDE INC's revenue compounded faster (14.5% CAGR vs 2.6%).
AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.
Wolverine World Wide is a global designer, manufacturer and marketer of branded footwear, apparel and accessories. It owns popular brands including Merrell, Sperry, Saucony and Hush Puppies, serving outdoor, casual, workwear and athletic segments via e-commerce, retail stores and global wholesale networks.
ATR vs WWW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $962.7M | $517.5M |
| Net Profit | $74.3M | $31.8M |
| Gross Margin | — | 47.3% |
| Operating Margin | 11.0% | 9.7% |
| Net Margin | 7.7% | 6.1% |
| Revenue YoY | 13.5% | 25.5% |
| Net Profit YoY | -26.4% | 162.8% |
| EPS (diluted) | $1.13 | $0.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $517.5M | ||
| Q4 25 | $962.7M | — | ||
| Q3 25 | $961.1M | $470.3M | ||
| Q2 25 | $966.0M | $474.2M | ||
| Q1 25 | $887.3M | $412.3M | ||
| Q4 24 | $848.1M | $494.7M | ||
| Q3 24 | $909.3M | $440.2M | ||
| Q2 24 | $910.1M | $425.2M |
| Q1 26 | — | $31.8M | ||
| Q4 25 | $74.3M | — | ||
| Q3 25 | $127.9M | $25.1M | ||
| Q2 25 | $111.7M | $26.8M | ||
| Q1 25 | $78.8M | $12.1M | ||
| Q4 24 | $100.9M | $23.1M | ||
| Q3 24 | $100.0M | $23.2M | ||
| Q2 24 | $90.5M | $13.8M |
| Q1 26 | — | 47.3% | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 47.5% | ||
| Q2 25 | — | 47.2% | ||
| Q1 25 | — | 47.2% | ||
| Q4 24 | — | 43.4% | ||
| Q3 24 | — | 45.1% | ||
| Q2 24 | — | 43.1% |
| Q1 26 | — | 9.7% | ||
| Q4 25 | 11.0% | — | ||
| Q3 25 | 14.2% | 8.4% | ||
| Q2 25 | 14.9% | 8.6% | ||
| Q1 25 | 12.8% | 4.8% | ||
| Q4 24 | 14.2% | 7.4% | ||
| Q3 24 | 15.2% | 7.9% | ||
| Q2 24 | 13.8% | 6.8% |
| Q1 26 | — | 6.1% | ||
| Q4 25 | 7.7% | — | ||
| Q3 25 | 13.3% | 5.3% | ||
| Q2 25 | 11.6% | 5.7% | ||
| Q1 25 | 8.9% | 2.9% | ||
| Q4 24 | 11.9% | 4.7% | ||
| Q3 24 | 11.0% | 5.3% | ||
| Q2 24 | 9.9% | 3.2% |
| Q1 26 | — | $0.37 | ||
| Q4 25 | $1.13 | — | ||
| Q3 25 | $1.92 | $0.30 | ||
| Q2 25 | $1.67 | $0.32 | ||
| Q1 25 | $1.17 | $0.15 | ||
| Q4 24 | $1.48 | $0.29 | ||
| Q3 24 | $1.48 | $0.28 | ||
| Q2 24 | $1.34 | $0.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $409.5M | — |
| Total DebtLower is stronger | $1.1B | $621.7M |
| Stockholders' EquityBook value | $2.7B | $408.0M |
| Total Assets | $5.3B | $1.7B |
| Debt / EquityLower = less leverage | 0.43× | 1.52× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $409.5M | — | ||
| Q3 25 | $264.8M | — | ||
| Q2 25 | $169.8M | — | ||
| Q1 25 | $136.8M | — | ||
| Q4 24 | $226.2M | — | ||
| Q3 24 | $327.9M | — | ||
| Q2 24 | $223.9M | — |
| Q1 26 | — | $621.7M | ||
| Q4 25 | $1.1B | — | ||
| Q3 25 | $546.0M | $676.4M | ||
| Q2 25 | $535.1M | $708.5M | ||
| Q1 25 | $561.2M | $710.8M | ||
| Q4 24 | $688.1M | $648.0M | ||
| Q3 24 | $822.7M | $702.8M | ||
| Q2 24 | $681.5M | $814.7M |
| Q1 26 | — | $408.0M | ||
| Q4 25 | $2.7B | — | ||
| Q3 25 | $2.8B | $376.7M | ||
| Q2 25 | $2.7B | $344.0M | ||
| Q1 25 | $2.5B | $310.6M | ||
| Q4 24 | $2.5B | $312.9M | ||
| Q3 24 | $2.5B | $295.2M | ||
| Q2 24 | $2.4B | $262.1M |
| Q1 26 | — | $1.7B | ||
| Q4 25 | $5.3B | — | ||
| Q3 25 | $5.1B | $1.7B | ||
| Q2 25 | $4.9B | $1.8B | ||
| Q1 25 | $4.5B | $1.7B | ||
| Q4 24 | $4.4B | $1.7B | ||
| Q3 24 | $4.6B | $1.8B | ||
| Q2 24 | $4.5B | $1.8B |
| Q1 26 | — | 1.52× | ||
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.20× | 1.80× | ||
| Q2 25 | 0.20× | 2.06× | ||
| Q1 25 | 0.22× | 2.29× | ||
| Q4 24 | 0.28× | 2.07× | ||
| Q3 24 | 0.32× | 2.38× | ||
| Q2 24 | 0.28× | 3.11× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $183.7M | $146.2M |
| Free Cash FlowOCF − Capex | $96.9M | $145.6M |
| FCF MarginFCF / Revenue | 10.1% | 28.1% |
| Capex IntensityCapex / Revenue | 9.0% | 0.1% |
| Cash ConversionOCF / Net Profit | 2.47× | 4.60× |
| TTM Free Cash FlowTrailing 4 quarters | $299.6M | $125.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $146.2M | ||
| Q4 25 | $183.7M | — | ||
| Q3 25 | $177.6M | $33.0M | ||
| Q2 25 | $126.0M | $44.6M | ||
| Q1 25 | $82.7M | $-83.8M | ||
| Q4 24 | $178.2M | $82.4M | ||
| Q3 24 | $229.3M | $108.2M | ||
| Q2 24 | $143.6M | $26.7M |
| Q1 26 | — | $145.6M | ||
| Q4 25 | $96.9M | — | ||
| Q3 25 | $114.3M | $30.1M | ||
| Q2 25 | $62.5M | $41.2M | ||
| Q1 25 | $25.9M | $-91.4M | ||
| Q4 24 | $112.2M | $74.4M | ||
| Q3 24 | $162.7M | $104.1M | ||
| Q2 24 | $75.4M | $23.7M |
| Q1 26 | — | 28.1% | ||
| Q4 25 | 10.1% | — | ||
| Q3 25 | 11.9% | 6.4% | ||
| Q2 25 | 6.5% | 8.7% | ||
| Q1 25 | 2.9% | -22.2% | ||
| Q4 24 | 13.2% | 15.0% | ||
| Q3 24 | 17.9% | 23.6% | ||
| Q2 24 | 8.3% | 5.6% |
| Q1 26 | — | 0.1% | ||
| Q4 25 | 9.0% | — | ||
| Q3 25 | 6.6% | 0.6% | ||
| Q2 25 | 6.6% | 0.7% | ||
| Q1 25 | 6.4% | 1.8% | ||
| Q4 24 | 7.8% | 1.6% | ||
| Q3 24 | 7.3% | 0.9% | ||
| Q2 24 | 7.5% | 0.7% |
| Q1 26 | — | 4.60× | ||
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | 1.31× | ||
| Q2 25 | 1.13× | 1.66× | ||
| Q1 25 | 1.05× | -6.93× | ||
| Q4 24 | 1.77× | 3.57× | ||
| Q3 24 | 2.29× | 4.66× | ||
| Q2 24 | 1.59× | 1.93× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
WWW
| Sales Channel Through Intermediary | $230.2M | 44% |
| Sales Channel Directly To Consumer | $142.6M | 28% |
| Work Group | $134.0M | 26% |
| Other | $10.7M | 2% |
